TCL Archive President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget February 5, 1999
TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014